Patent · US Active

Methods and kits for diagnosis of cancer and prediction of therapeutic value

US10517969B2 · kind B2 · utility

0Cited by

172References

9Claims

0Family size

Assignee

Cornell University · IT

Inventors

Neil H. Bander · Chappaqua, US
Joseph Osborne · New York, US
Stanley Goldsmith · Floral Park, US
Shankar Vallabhajosula · Larchmont, US

Key dates

Filing date	Feb 17, 2010
Grant date	Dec 31, 2019
Priority date	—
Expiry date	Feb 17, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for identifying a patient for cancer therapy can include administering a diagnostic dose of a detectably labeled first binding agent to a patient, the detectably labeled binding agent being capable of binding a molecular target. The method also includes selecting a patient for administration of a therapeutic dose of a second binding agent capable of binding a cellular target, wherein the selected patient exhibits a positive reading for the detectably labeled first binding agent. Furthermore, the method can include administering a therapeutic dose of the second binding agent to the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.